Related by context. Frequent words. (Click for all words.) 69 BLA submission 64 Investigational Device Exemption 63 Marketing Authorization Application 63 PREOS 63 Biologics License Application BLA 63 confirmatory Phase III 63 NDA submission 63 Biologics License Application 62 Complete Response 62 sBLA 62 phase IIa 61 Marketing Authorization Application MAA 61 OFIRMEV 61 Pivotal Trial 61 Phase 2b study 60 PROPEL trial 60 Investigational Device Exemption IDE 60 Icatibant 60 CORTOSS 60 Pivotal Phase III 60 ponatinib 60 confirmatory Phase 3 59 AspenBio 59 registrational 59 sNDA 59 alvimopan 59 BEMA Fentanyl 59 INDs 59 Acetavance 58 Vilazodone 58 phase IIb 58 SFDA approval 58 FavId 58 JZP 6 58 Phase III 58 Phase Ib 57 pharmacokinetic studies 57 MOZOBIL 57 CoFactor 57 NUVIGIL 57 alogliptin 57 Phase 2a trial 57 Stedivaze 57 TOCOSOL Paclitaxel 57 Phase IIb 57 Phase III clinical 56 IND enabling 56 Phase IIa trial 56 Genasense R oblimersen 56 PFO closure 56 Endeavor stent 56 APF# 56 Phase III trials 56 Azedra 56 SILENOR TM 56 teduglutide 56 Novacor LVAS 56 Destination Therapy 56 Pivotal Phase 56 pivotal Phase III 56 Phase IIb trial 56 PhosLo 56 Zelrix 56 Stelara 56 vilazodone 56 methylnaltrexone 56 Exalgo 56 Marqibo 56 Phase III pivotal 55 tanespimycin 55 cangrelor 55 Gabapentin GR 55 Approvable Letter 55 PDUFA date 55 Coronary Stent 55 Phase 1b trial 55 phase 2a 55 ATryn R 55 Investigational 55 Anturol 55 Viprinex 55 eniluracil 55 Onsolis 55 Ceplene 55 FDA Clearance 55 Complete Response letter 55 tezampanel 55 Phase IIa clinical trials 55 StaphVAX 55 Phase III Trial 55 orphan designation 55 multicenter clinical 55 New Drug Application 55 SinuNase 55 Neuradiab 55 Rhucin ® 55 Phase 2a clinical 55 maribavir 55 CHMP opinion 54 MBP# [001] 54 Asentar